Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: Critical role of Noxa-mediated lipid peroxidation

41Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

Increased expression of antiapoptotic Bcl-2 proteins confers therapeutic resistance in various cancer types. Targeting Bcl-2 proteins by small molecules or activating alternative pathways to bypass Bcl-2-mediated protection to promote apoptosis are two approaches to overcoming therapeutic resistance. Here, we show that cisplatin triggers a Bak-dependent pathway to induce apoptosis in Bcl-2-overexpressing MCF-7 cells. p53-mediated induction of Noxa expression, generation of lipid peroxidation end products and induction of Noxa-Mcl-1 interaction are necessary for this pathway to function. Although Puma is also induced by cisplatin treatment, it is not required for apoptosis. Similarly, reactive oxygen species production by cisplatin did not have any effect on cisplatin-induced apoptosis in MCF-7 Bcl-2 cells. Furthermore, p53 promotes cisplatin-induced apoptosis by directly binding and counteracting Bcl-xL antiapoptotic function. In conclusion, our findings suggest a novel mode of action for cisplatin to overcome Bcl-2-mediated protection against apoptosis, which requires preferential activation of Bak and p53-mediated upregulation of Noxa protein levels and lipid peroxidation. © The Author 2009. Published by Oxford University Press. All rights reserved.

References Powered by Scopus

Mitochondria and apoptosis

8480Citations
N/AReaders
Get full text

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

6196Citations
N/AReaders
Get full text

Bcl-2 functions in an antioxidant pathway to prevent apoptosis

3377Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cellular responses to cisplatin-induced DNA damage

430Citations
N/AReaders
Get full text

Subcellular targets of cisplatin cytotoxicity: An integrated view

156Citations
N/AReaders
Get full text

The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo

110Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kutuk, O., Arisan, E. D., Tezil, T., Shoshan, M. C., & Basaga, H. (2009). Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: Critical role of Noxa-mediated lipid peroxidation. Carcinogenesis, 30(9), 1517–1527. https://doi.org/10.1093/carcin/bgp165

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 18

58%

Researcher 8

26%

Professor / Associate Prof. 4

13%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 11

39%

Agricultural and Biological Sciences 10

36%

Pharmacology, Toxicology and Pharmaceut... 4

14%

Chemistry 3

11%

Save time finding and organizing research with Mendeley

Sign up for free